Dealmakers newsletter: July 2008

Welcome to July's edition of the Dealmakers newsletter from CurrentPartnering.

Sponsored by: Intralinks | Verticali | EuroPLX | DMS Data Systems

If not already signed up to receive our newsletters, do so here.

In this issue:

Editor's corner
NEW: Networks launched
New partnering reports
In the news - June/July 2008
New best practice articles
Forthcoming events
Advisers - new entrant to our directory
Scorecards - newly updated with latest deals
People on the move
Partnering resources: Partnering organizations
Glossary of partnering terms

The July issue of Dealmakers is sponsored by:

BioBusiness Network 2008

For more information, please visit the conference website

EDITOR'S CORNER

July sees the launch of our NETWORKS section - providing dealmakers with access to the CurrentPartnering Business Development Network at LinkedIn and Facebook - more:

Networks

Dealmaking has really picked up in the second quarter of 2008.

June saw the announcement of $1bn+ deals:

Invitrogen's acquisition of Applied Biosystems for $6,700m
DaiichiSankyo's equity purchase in Ranbaxy for $4,600m
Sanofi-Aventis' acquisition offer for Zentiva for $2,600m
GlaxoSmithKline's partnering deal with Mpex for efflux pump inhibitors for infections for a headline value $1,750m

Finally, we have been busy in our report publishing activities - our latest report is now available Clinical Stage Partnering Agreements in Biopharma.

The report provides a comprehensive overview of phase I, II and III partnering deals and includes a full directory of partnering contract documents, allowing the user to access detailed deal terms and not just summary details found in press releases.

The report adds to our growing portfolio of Agreements in Biopharma reports covering Co-promotion and Co-marketing, Merger and Acquisition, Manufacturing and Supply, Distribution, and Bigpharma.

You can also view the leading deals so far this year in our updated Scorecards.

Until next time - happy dealmaking!

Steve Poile

NETWORKS LAUNCHED!

Networks facilitates the connecting of business developers in biopharma through the use of social networkings tools - including LinkedIn, Facebook, Twitter and GoogleMaps.

To join or participate in CurrentPartnering's Network tools, just click on the link below for further details:

Networks - join now!

NEW PARTNERING REPORTS

Clinical Stage Partnering Agreements in Biopharma

The Clinical Stage Partnering Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the clinical stage partnering agreements entered into by the worlds leading biopharma companies Clinical Stage Partnering Agreements in Biopharma report.

Manufacturing and Supply Agreements in Biopharma

The Manufacturing and Supply Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the manufacturing and supply partnering agreements entered into by the worlds leading biopharma companies Manufacturing and Supply Agreements in Biopharma

Co-promotion & Co-marketing Agreements in Biopharma

The Co-promotion and Co-marketing Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies Co-promotion & Co-marketing Agreements in Biopharma

Also:

more reports/books

IN THE NEWS

The latest partnering developments - June/July 2008:

Innogenetics grants cervical cancer licence to GlaxoSmithKline
Bayer and Maxygen in hematology deal
Schering-Plough completes divestiture of selected animal health products
Cubist to promote AstraZeneca's broad spectrum antibiotic MERREM in USA
Bioniche acquires Baxter's ENLON and ENLON-PLUS
Palatin amendment expands AstraZeneca obesity collaboration
NovaMed to market six cancer drugs in China for Pfizer
GlaxoSmithKline sells four drugs to Aspen Pharmacare

more news

NEW BEST PRACTICE ARTICLES

IP Due Diligence Readiness

This article explains the importance of doing an IP due diligence upon oneself to reduce or eliminate risks associated with licensing, seeking capital for a start up or while planning for a trade sale of IP read more here

The Role of Competition in Bio-Technological Patenting and Innovation

This article examines the phenomenon of patenting as a strategy not so much to protect innovations but as a means of securing bargaining chips for access to others’ proprietary technologies read more

FORTHCOMING EVENTS

Here is our suggested partnering events for the fall of 2008.

BioPharm America 2008

Buckland, Atlanta, USA - September 9-10, 2008

BioPharm America is where biotech industry partnerships get started. Based on the same winning formula used in EBD Group’s distinguished European partnering conferences BIO-Europe and BIO-Europe Spring, BioPharm America is expected to become the premier stand-alone bio-pharma partnering event in North America BioPharm America 2008

BioBusiness Network 2008

Geneva, Switzerland - September 16-18, 2008

The Premier Global Bio-Partnering Event BioBusiness Network 2008

Pharmaceutical Strategic Alliances 2008

Marriott Financial Center, New York City, NY, USA - September 23-25, 2008

Meet the Most Important People in Dealmaking…The only conference that provides 100% case studies by CEOs and Senior Executives in the industry Pharmaceutical Strategic Alliances 2008

EuroPLX 37 Dresden

Dresden, Germany - October 6-7, 2008

Collaborative agreements in generics (incl. bio-generics and biosimilars), OTC drugs, and nutraceuticals EuroPLX 37 Dresden

4th Modern Drug Discovery & Development Summit

San Diego, CA, USA - October 15-17, 2008

The Modern Drug Discovery & Development Summit delivers a powerful package as the brightest minds in the pharmaceutical and biotechnological industries converge to share ideas and new developments in drug discovery - 4th Modern Drug Discovery & Development Summit

more events

SCORECARDS

Our scorecards are updated with the latest deals to break into our most valuable deal rankings - the latest deal for 2008 to enter our partnering top 20 is GlaxoSmithKline and Mpex's $1,750m deal to give GSK access to Mpex's efflux pump inhibitor technology for use in treatment of gram-negative infections.

Partnering Top 20 - 2008
Partnering Top 20 - 2007
Partnering since 2000
M&A Top 20 - 2008
M&A Top 20 - 2007
M&A since 2000
Bigpharma Top 25 partnering - 2008

View latest updates

PEOPLE ON THE MOVE

The following people have been reported on the move during the weeks of June/July 2008:

Erik Holmlin, Diana Wood, William Lis, Thomas Bliss, Jim Meade, Roger McDonald, Anindya Chatterjee to name just a few

If you have news about a business development executive who is on the move - let us know

PARTNERING RESOURCES: PARTNERING ORGANIZATIONS

An up to date list of partnering organisations worldwide, each offering support, advice, and peer networking opportunities - Partnering organizations

GLOSSARY: UPDATED PARTNERING TERMS

The most recent addition is SPC or Supplementary Protection Certificate - a concession granted to pharma to extend protection under a patent more details

Full Glossary can be accessed here

Do you have specific glossary terms that you would like to see in our website? Give us your ideas here

CurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers

Advertizing and sponsorship

CurrentPartnering offers several advertising options, enabling your product or service to be promoted to our global business development audience - further details available online.

or contact us to discuss your requirements.

Steve Poile, Editor

Web: http://www.CurrentPartnering.com

Mail: CurrentPartnering, Allanmere House, 6 Hobgate, York, YO24 4HF, United Kingdom

Tel: +44 7896 656732

Fax: +44 8703 305993